Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis.

Landau H, Lahoud O, Devlin S, Lendvai N, Chung DJ, Dogan A, Landgren CO, Giralt S, Hassoun H.

Biol Blood Marrow Transplant. 2019 Aug 22. pii: S1083-8791(19)30530-0. doi: 10.1016/j.bbmt.2019.08.016. [Epub ahead of print]

PMID:
31446197
2.

Monoclonal gammopathy-associated thrombotic microangiopathy.

Yui JC, Garceau D, Jhaveri KD, Wanchoo R, Bijol V, Glezerman I, Hassoun H, Dispenzieri A, Russell SJ, Leung N.

Am J Hematol. 2019 Oct;94(10):E250-E253. doi: 10.1002/ajh.25569. Epub 2019 Jul 17. No abstract available.

PMID:
31257598
3.

[Psychometric validation of the brief Humanizar Scale on the meaning of suffering].

Villacieros M, Bermejo JC, Hassoun H.

J Healthc Qual Res. 2019 Mar - Apr;34(2):86-92. doi: 10.1016/j.jhqr.2019.01.003. Epub 2019 Mar 28. Spanish.

PMID:
30928324
4.

Multiple myeloma with simultaneous cutaneous and central nervous system involvement.

Nguyen J, Hassoun H.

Clin Case Rep. 2018 Sep 5;6(10):2015-2016. doi: 10.1002/ccr3.1626. eCollection 2018 Oct.

5.

Immunocytochemical analysis of valproic acid induced histone H3 and H4 acetylation during differentiation of rat adipose derived stem cells into neuron-like cells.

Rezaei F, Tiraihi T, Abdanipour A, Hassoun HK, Taheri T.

Biotech Histochem. 2018;93(8):589-600. doi: 10.1080/10520295.2018.1511063. Epub 2018 Oct 1.

PMID:
30273059
6.

Opportunities and challenges in the current era of global medical education.

Rizwan M, Rosson N, Tackett S, Hassoun H.

Int J Med Educ. 2018 Apr 27;9:111-112. doi: 10.5116/ijme.5ad1.ce9a. No abstract available.

7.

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity.

Lendvai N, Tsakos I, Devlin SM, Schaffer WL, Hassoun H, Lesokhin AM, Landau H, Korde N, Mailankody S, Smith E, Chung DJ, Koehne G, Shah GL, Alexander A, Patel M, Ballagi A, Grundberg I, Giralt SA, Landgren O.

Leuk Lymphoma. 2018 Aug;59(8):1981-1985. doi: 10.1080/10428194.2017.1403020. Epub 2018 Jan 8. No abstract available.

8.

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.

Palazzo M, Shah GL, Copelan O, Seier K, Devlin SM, Maloy M, Kenny S, Hassoun H, Korde NS, Lendvai N, Lesokhin AM, Mailankody S, Chung DJ, Koehne G, Landgren CO, Landau H, Giralt SA, Perales MA.

Biol Blood Marrow Transplant. 2018 Apr;24(4):871-876. doi: 10.1016/j.bbmt.2017.12.795. Epub 2017 Dec 27.

9.

[Validation of the Scale of Hope in Terminal Illness for relatives brief version (SHTI-b). Validity and reliability analysis.]

Villacieros M, Bermejo JC, Hassoun H.

An Sist Sanit Navar. 2017 Dec 29;40(3):391-400. doi: 10.23938/ASSN.0118. Spanish.

10.

Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.

Pun SC, Landau HJ, Riedel ER, Jordan J, Yu AF, Hassoun H, Chen CL, Steingart RM, Liu JE.

J Am Soc Echocardiogr. 2018 Jan;31(1):64-70. doi: 10.1016/j.echo.2017.08.017. Epub 2017 Oct 27.

11.

Global collaborative healthcare: assessing the resource requirements at a leading Academic Medical Center.

Rosson NJ, Hassoun HT.

Global Health. 2017 Sep 20;13(1):76. doi: 10.1186/s12992-017-0298-5. Review.

12.

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL.

Lancet Haematol. 2017 Sep;4(9):e431-e442. doi: 10.1016/S2352-3026(17)30140-0. Epub 2017 Aug 17. Erratum in: Lancet Haematol. 2018 Aug;5(8):e332. Lancet Haematol. 2018 Dec;5(12):e608.

13.

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.

Pianko MJ, Funt SA, Page DB, Cattry D, Scott EC, Ansell SM, Borrello IM, Gutierrez M, Lendvai N, Hassoun H, Landgren CO, Lesokhin AM.

Leuk Lymphoma. 2018 Jan;59(1):221-224. doi: 10.1080/10428194.2017.1320713. Epub 2017 May 30. No abstract available.

14.

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance.

Hassoun H, Roshal M, Sabari J, Nguyen J, Gao Q, Devlin SM, Landau H, Lendvai N, Chung DJ, Lesokhin AM, Korde N, Mailankody S, Dogan A, Giralt SA, Landgren CO.

Leuk Lymphoma. 2017 Dec;58(12):2962-2965. doi: 10.1080/10428194.2017.1312382. Epub 2017 May 9. No abstract available.

PMID:
28482750
15.

Total Fluorescence Fingerprinting of Pesticides: A Reliable Approach for Continuous Monitoring of Soils and Waters.

Hassoun H, Lamhasni T, Foudeil S, El Bakkali A, Ait Lyazidi S, Haddad M, Choukrad M, Hnach M.

J Fluoresc. 2017 Sep;27(5):1633-1642. doi: 10.1007/s10895-017-2100-8. Epub 2017 Apr 14.

PMID:
28411311
16.

Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.

Shah GL, Landau H, Londono D, Devlin SM, Kosuri S, Lesokhin AM, Lendvai N, Hassoun H, Chung DJ, Koehne G, Jhanwar SC, Landgren O, Levine R, Giralt SA.

Leuk Lymphoma. 2017 Aug;58(8):1823-1831. doi: 10.1080/10428194.2016.1260126. Epub 2017 Jan 12.

17.

Proteomic profiling in plasma cell disorders: a feasibility study.

Mailankody S, Devlin SM, Korde N, Lendvai N, Lesokhin A, Landau H, Hassoun H, Ballagi A, Ekman D, Chung DJ, Patel M, Koehne G, Giralt S, Landgren O.

Leuk Lymphoma. 2017 Jul;58(7):1757-1759. doi: 10.1080/10428194.2016.1258699. Epub 2016 Dec 2. No abstract available.

18.

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.

Ogunniyi A, Rodriguez M, Devlin S, Adel N, Landau H, Chung DJ, Lendvai N, Lesokhin A, Koehne G, Mailankody S, Korde N, Reich L, Landgren O, Giralt S, Hassoun H.

Leuk Lymphoma. 2017 May;58(5):1123-1129. doi: 10.1080/10428194.2016.1239261. Epub 2016 Oct 13.

19.

Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood.

Murata K, McCash SI, Carroll B, Lesokhin AM, Hassoun H, Lendvai N, Korde NS, Mailankody S, Landau HJ, Koehne G, Chung DJ, Giralt SA, Ramanathan LV, Landgren O.

Clin Biochem. 2018 Jan;51:66-71. doi: 10.1016/j.clinbiochem.2016.09.015. Epub 2016 Sep 21.

20.

Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis.

Landau H, Smith M, Landry C, Chou JF, Devlin SM, Hassoun H, Bello C, Giralt S, Comenzo RL.

Leukemia. 2017 Jan;31(1):136-142. doi: 10.1038/leu.2016.229. Epub 2016 Aug 18.

21.

Vertebral Uptake of Tc-99m Macroaggregated Albumin (MAA) with SPECT/CT Occurring in Superior Vena Cava Obstruction.

Karls S, Hassoun H, Derbekyan V.

Nucl Med Mol Imaging. 2016 Sep;50(3):266-9. doi: 10.1007/s13139-015-0372-y. Epub 2016 Jan 25.

22.

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma.

Lendvai N, Yee AJ, Tsakos I, Alexander A, Devlin SM, Hassoun H, Korde N, Lesokhin AM, Landau H, Mailankody S, Koehne G, Chung DJ, Landgren O, Raje NS, Giralt S.

Blood. 2016 May 12;127(19):2355-6. doi: 10.1182/blood-2016-01-694786. Epub 2016 Mar 28. No abstract available.

23.

Creatine Enhances Transdifferentiation of Bone Marrow Stromal Cell-Derived Neural Stem Cell Into GABAergic Neuron-Like Cells Characterized With Differential Gene Expression.

Darabi S, Tiraihi T, Delshad A, Sadeghizadeh M, Taheri T, Hassoun HK.

Mol Neurobiol. 2017 Apr;54(3):1978-1991. doi: 10.1007/s12035-016-9782-9. Epub 2016 Feb 24.

PMID:
26910814
24.

Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.

Landau H, Wood K, Chung DJ, Koehne G, Lendvai N, Hassoun H, Lesokhin A, Hoover E, Zheng J, Devlin SM, Giralt S.

Leuk Lymphoma. 2016 Aug;57(8):1781-5. doi: 10.3109/10428194.2015.1121256. Epub 2016 Jan 12.

25.

Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study.

Afifi S, Adel NG, Devlin S, Duck E, Vanak J, Landau H, Chung DJ, Lendvai N, Lesokhin A, Korde N, Reich L, Landgren O, Giralt S, Hassoun H.

Bone Marrow Transplant. 2016 Apr;51(4):546-52. doi: 10.1038/bmt.2015.322. Epub 2016 Jan 4.

PMID:
26726942
26.

18F-FDG PET/CT Imaging of Bilateral Renal Metastasis of Breast Adenoid Cystic Carcinoma.

Hassoun H, Alabed YZ, Karls S, Probst S, Laufer J.

Clin Nucl Med. 2016 Feb;41(2):148-9. doi: 10.1097/RLU.0000000000001047.

PMID:
26562575
27.

CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.

Smith E, Devlin SM, Kosuri S, Orlando E, Landau H, Lesokhin AM, Chung DJ, Hassoun H, Lendvai N, Landgren O, Giralt S, Chari A, Jagannath S, Koehne G.

Biol Blood Marrow Transplant. 2016 Feb;22(2):258-267. doi: 10.1016/j.bbmt.2015.08.025. Epub 2015 Aug 30.

28.

Minimal residual disease in multiple myeloma: bringing the bench to the bedside.

Mailankody S, Korde N, Lesokhin AM, Lendvai N, Hassoun H, Stetler-Stevenson M, Landgren O.

Nat Rev Clin Oncol. 2015 May;12(5):286-95. doi: 10.1038/nrclinonc.2014.239. Epub 2015 Jan 27. Review.

PMID:
25622976
29.

Catalog of total excitation-emission and total synchronous fluorescence maps with synchronous fluorescence spectra of homologated fluorescent pesticides in large use in Morocco: development of a spectrometric low cost and direct analysis as an alert method in case of massive contamination of soils and waters by fluorescent pesticides.

Foudeil S, Hassoun H, Lamhasni T, Ait Lyazidi S, Benyaich F, Haddad M, Choukrad M, Boughdad A, Bounakhla M, Bounouira H, Duarte RM, Cachada A, Duarte AC.

Environ Sci Pollut Res Int. 2015 May;22(9):6766-77. doi: 10.1007/s11356-014-3807-6. Epub 2014 Nov 27.

PMID:
25424031
30.

Improvement of spinal contusion model by cotransplanting bone marrow stromal cells and induced BMSCs into oligodendrocytes-like cells.

Kaka GR, Tiraihi T, Delshad A, Taheri T, Kazemi H, Hassoun HK.

J Neurosurg Sci. 2017 Oct;61(5):486-494. doi: 10.23736/S0390-5616.16.03061-7. Epub 2014 Oct 6.

PMID:
25283064
31.

Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis.

Reece DE, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Bladé J, Fermand JP, Hassoun H, Heffner L, Kukreti V, Vescio RA, Pei L, Enny C, Esseltine DL, van de Velde H, Cakana A, Comenzo RL.

Blood. 2014 Oct 16;124(16):2498-506. doi: 10.1182/blood-2014-04-568329. Epub 2014 Sep 8.

32.

Differentiation of neurosphere-derived rat neural stem cells into oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine.

Abbaszadeh HA, Tiraihi T, Delshad A, Saghedizadeh M, Taheri T, Kazemi H, Hassoun HK.

Tissue Cell. 2014 Dec;46(6):462-9. doi: 10.1016/j.tice.2014.08.003. Epub 2014 Aug 20.

PMID:
25200619
33.

A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma.

Lendvai N, Hilden P, Devlin S, Landau H, Hassoun H, Lesokhin AM, Tsakos I, Redling K, Koehne G, Chung DJ, Schaffer WL, Giralt SA.

Blood. 2014 Aug 7;124(6):899-906. doi: 10.1182/blood-2014-02-556308. Epub 2014 Jun 24.

34.

A case of protothecosis in a patient with multiple myeloma.

Figueroa CJ, Camp BJ, Varghese GI, Miranda E, Querfeld C, Hassoun H, Kamboj M, Pulitzer MP.

J Cutan Pathol. 2014 May;41(5):409-13. doi: 10.1111/cup.12338. No abstract available.

PMID:
24758253
35.

Current strategies for treatment of relapsed/refractory multiple myeloma.

Laubach JP, Voorhees PM, Hassoun H, Jakubowiak A, Lonial S, Richardson PG.

Expert Rev Hematol. 2014 Feb;7(1):97-111. doi: 10.1586/17474086.2014.882764. Epub 2014 Jan 29. Review.

PMID:
24471924
36.

Venous thromboembolic disease.

Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogerty AE, Gao S, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Siddiqi T, Smith JL, Yee GC, Zakarija A, McMillian N, Naganuma M; National comprehensive cancer network.

J Natl Compr Canc Netw. 2013 Nov;11(11):1402-29.

PMID:
24225973
37.

Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis.

White LE, Hassoun HT, Bihorac A, Moore LJ, Sailors RM, McKinley BA, Valdivia A, Moore FA.

J Trauma Acute Care Surg. 2013 Sep;75(3):432-8. doi: 10.1097/TA.0b013e31829de6cd.

38.

Single-stage repair of a complex type B aortic dissection associated with a pressurized infrarenal abdominal aortic aneurysm.

Patel MS, Hassoun HT, Davies MG, Lumsden AB.

Ann Vasc Surg. 2013 Nov;27(8):1182.e9-12. doi: 10.1016/j.avsg.2012.10.035. Epub 2013 Aug 26.

PMID:
23988550
39.

Challenging diagnosis of intra-diverticular colonic adenocarcinoma with submucosal localization.

Parsyan A, Cardin MJ, Hassoun H, Andalib A, Tataryn D, Meterissian S, Roy I.

Int J Colorectal Dis. 2013 Dec;28(12):1735-7. doi: 10.1007/s00384-013-1720-y. Epub 2013 Jun 1. No abstract available.

PMID:
23728595
40.

Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance.

Zamarin D, Devlin SM, Arcila ME, Landau H, Lesokhin A, Lendvai N, Chung DJ, Chimento D, Weltz J, Babu D, Giralt S, Hassoun H.

Leukemia. 2013 Dec;27(12):2422-4. doi: 10.1038/leu.2013.126. Epub 2013 Apr 23. No abstract available.

PMID:
23608883
41.

In situ fenestration for branch vessel preservation during EVAR.

Bismuth J, Duran C, Hassoun HT.

Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):33-6. Review. No abstract available.

42.

Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center.

Pozotrigo M, Adel N, Landau H, Lesokhin A, Lendvai N, Chung DJ, Chimento D, Riedel E, Chen X, Reich L, Comenzo R, Giralt S, Hassoun H.

Bone Marrow Transplant. 2013 Aug;48(8):1033-9. doi: 10.1038/bmt.2012.281. Epub 2013 Jan 21.

PMID:
23334269
43.

Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis.

Landau H, Hassoun H, Rosenzweig MA, Maurer M, Liu J, Flombaum C, Bello C, Hoover E, Riedel E, Giralt S, Comenzo RL.

Leukemia. 2013 Apr;27(4):823-8. doi: 10.1038/leu.2012.274. Epub 2012 Sep 27.

PMID:
23014566
44.

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.

Witzig TE, Laumann KM, Lacy MQ, Hayman SR, Dispenzieri A, Kumar S, Reeder CB, Roy V, Lust JA, Gertz MA, Greipp PR, Hassoun H, Mandrekar SJ, Rajkumar SV.

Leukemia. 2013 Jan;27(1):220-5. doi: 10.1038/leu.2012.236. Epub 2012 Aug 20.

45.

Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation.

Zamarin D, Giralt S, Landau H, Lendvai N, Lesokhin A, Chung D, Koehne G, Chimento D, Devlin SM, Riedel E, Bhutani M, Babu D, Hassoun H.

Bone Marrow Transplant. 2013 Mar;48(3):419-24. doi: 10.1038/bmt.2012.151. Epub 2012 Aug 13.

46.

Lung T lymphocyte trafficking and activation during ischemic acute kidney injury.

Lie ML, White LE, Santora RJ, Park JM, Rabb H, Hassoun HT.

J Immunol. 2012 Sep 15;189(6):2843-51. doi: 10.4049/jimmunol.1103254. Epub 2012 Aug 10.

47.

Lung endothelial cell apoptosis during ischemic acute kidney injury.

White LE, Cui Y, Shelak CM, Lie ML, Hassoun HT.

Shock. 2012 Aug;38(3):320-7. doi: 10.1097/SHK.0b013e31826359d0.

PMID:
22777112
48.

TNFR1-dependent pulmonary apoptosis during ischemic acute kidney injury.

White LE, Santora RJ, Cui Y, Moore FA, Hassoun HT.

Am J Physiol Lung Cell Mol Physiol. 2012 Sep;303(5):L449-59. doi: 10.1152/ajplung.00301.2011. Epub 2012 Jun 22.

49.

Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma.

Khan S, Chen CL, Brady MS, Parameswaran R, Moore R, Hassoun H, Carvajal RD.

J Clin Oncol. 2012 Jun 20;30(18):e163-4. doi: 10.1200/JCO.2011.38.7852. Epub 2012 May 14. No abstract available.

PMID:
22585705
50.

Lenalidomide after stem-cell transplantation for multiple myeloma.

McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C.

N Engl J Med. 2012 May 10;366(19):1770-81. doi: 10.1056/NEJMoa1114083.

Supplemental Content

Loading ...
Support Center